SES AI is revolutionizing the electric vehicle market with advanced battery technology, boasting an 18-month lead over competitors. The company’s strong financial backing, robust technological edge, and joint development agreements with major auto manufacturers position it for success. With catalysts expected to drive share prices higher in 2024, SES AI presents a solid investment opportunity.
The mass adoption of battery electric vehicles (BEVs) faces obstacles due to freezing temperatures, reducing range and accessibility to chargers. General Motors confronts challenges with consumer pushback, battery manufacturing, and BEV models like the Buick Wildcat and Chevrolet Blazer. Honda’s withdrawal from a joint venture and GM’s $10 billion stock buyback reflect industry uncertainties. Amid this, GM’s CEO emphasizes the enduring potential of internal combustion vehicles and suggests a shift towards gas-electric hybrids.
Alphabet’s slow move into generative AI may impact its advertising revenue as it competes with ad-free GPT models. The company’s strengths lie in cloud growth, but maintaining shareholder expectations is a challenge. With a focus on AI and cloud, the company’s revenue outlook remains positive, but margin concerns persist in the evolving landscape.
The Bid’s episode on cryptocurrencies explores their impact and potential for investors. Head of Digital Assets at BlackRock and Chief Investment Officer discuss the significance of digital assets, the history and future of Bitcoin, and the regulatory landscape. They also address the challenges and opportunities digital assets bring to traditional investments and market structures.
Tesla, Inc. stands as a key player in the EV charging market due to its strategic Supercharger network, offering high-speed, strategically located charging stations. Their mission to accelerate EV adoption sets them apart, despite competition and regulatory challenges. Partnerships with companies like Buc-ee’s and adoption of their charging standard by major automakers add to their growth potential.
Microsoft (NASDAQ:MSFT) has experienced a 56% YTD increase, raising questions about its valuation. With dominant market positions in productivity, cloud, and personal computing, Microsoft’s solid growth prospects and improving margins support a “Buy” rating with a short-term price target of $400. The Bear and Bull Case scenarios suggest a current undervaluation of up to 37%.
As the influence of Artificial Intelligence (AI) rises into 2024, attention is turning toward chipmaker Nvidia. Experts expect Nvidia’s thriving stock, which has seen a 200% increase in value, to boost ETFs with exposure to it. The capabilities of AI depend significantly on chips, an area where Nvidia excels, potentially leading to more competition as AI’s growth continues. The American Century Focused Dynamic Growth ETF includes Nvidia as a major holding, indicating a focus on companies with notable growth.
Google has shown strong resilience in 2023, bouncing back after the disappointing results in 2022 with a rebound in the online advertising industry. Despite missing Wall Street’s cloud revenue expectations, Google has demonstrated a shift in strategy, focusing more on cost optimization and efficiency, instead of purely seeking growth. Such a shift, coupled with Google’s dominance in the advertising industry, makes it a potentially interesting investment opportunity at current prices.
“Disruptive innovation” technologies, such as artificial intelligence, are being utilized by tech companies for complex data analysis and creating notable progress in fields like healthcare and energy. According to Morningstar’s chief U.S. market strategist, Dave Sekera, investing in such tech can be challenging due to its vast scope. However, the Morningstar Exponential Technologies Index holds approximately 200 stocks which are anticipated to gain significant economic benefits from these innovations. Among these, 18 are highlighted as the best based on their competitive advantages and strong management teams.
Swedish group Northvolt has introduced sodium-ion batteries, a more sustainable and cost-effective alternative to lithium-ion batteries popular in EVs. The new batteries could alleviate EV manufacturers’ dependence on China for lithium and other critical minerals. Despite current lower energy density, Northvolt’s batteries are safer and cheaper, with promising applications in hotspot regions like India, Africa, and the Middle East. Mainly designed for electricity storage plants, future iterations of sodium-ion batteries may be compatible with EVs as their energy density improves.
Moderna and Merck’s shared mRNA-based skin cancer vaccine, MRNA-4157, has shown promising results in a Phase II trial, combined with Merck’s immunotherapy Keytruda. The study showed a 49% reduction in cancer recurrence or death risk, up from a 44% reduction about a year earlier, indicating a potential contribution beyond Moderna’s COVID-19 vaccine, Spikevax. Despite declining Spikevax sales due to global vaccination efforts, Moderna’s diverse portfolio of innovative therapies, like MRNA-4157, positions the company for future growth.
Microsoft’s Ignite Conference revealed significant technological innovations, specifically in Commercial Cloud and Generational Artificial Intelligence (GenAI) sectors. Microsoft unveiled its custom Azure silicon chips, potentially revolutionizing cloud computing and AI. The company also launched Microsoft 365 Copilot, aiming to enhance productivity across various sectors. Despite fierce competition and premium trading, Microsoft’s commitment to innovation, strategic alliances, robust technology investment, and solid financial health position it well for future growth.
Gene editing, particularly through the use of the revolutionary CRISPR-Cas9 tool, can modify the DNA of organisms directly, allowing scientists to alter genetic material at precise locations in the genome. The technology, which has aroused substantial interest amongst biotech companies, holds significant potential to transform health care by offering treatments for genetic disorders through precise genetic corrections. However, concerns over off-target effects, efficacy and ethical issues surrounding human germline editing remain prevalent.
As we near the first anniversary of ChaptGPT’s launch, stock investors question the valuation of AI companies and if 2023 was really the “year of AI”. Nvidia has particularly stood out, with its market capitalization rising substantially. Its performance and influence in the sector are unparalleled. Nevertheless, the broad AI ecosystem still holds potential and investment opportunities, especially with AI gradually permeating everyday software experiences. WisdomTree advises investors to consider a wide range of AI companies that could benefit from the growth of this emerging sector.
